Development of Cell-Based Sentinels for Nitric Oxide: Ensuring Marker Expression and Unimodality

ACS Synth Biol. 2018 Jul 20;7(7):1694-1701. doi: 10.1021/acssynbio.8b00146. Epub 2018 Jul 9.

Abstract

We generated "sentinel" bacteria that respond to the biomarker nitric oxide (NO) and produce a homogeneous and strong fluorescent response. Our dual-plasmid system consists of a signal "relay" vector that employs an NO-responsive promoter that amplifies the native signal (via expression of T7 Polymerase (T7Pol)) to a second vector responsible for GFP expression. Importantly, to achieve an optimal "sentinel" response, we developed strategies that balance the transcriptional load within cells by altering (i) translation and (ii) activity of the T7Pol. Our optimized genetic circuitry was then used to transform commensal E. coli Nissle, as a proof-of-concept toward an ingestible cell-based sensor for Crohn's disease (CD) that, in turn, is marked by elevated levels of intestinal NO. Thus, the "biosensors" demonstrated here may serve as a simple diagnostic tool, contrasting the standard of care including colonoscopies or biopsies.

Keywords: biosensor; inflammatory bowel disease; probiotics; signal amplification; synthetic biology.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Biomarkers
  • Biosensing Techniques
  • Crohn Disease / immunology
  • Crohn Disease / metabolism
  • Crohn Disease / microbiology
  • Escherichia coli / metabolism
  • Humans
  • Inflammatory Bowel Diseases / metabolism
  • Nitric Oxide / metabolism*
  • Promoter Regions, Genetic / genetics
  • Synthetic Biology / methods

Substances

  • Biomarkers
  • Nitric Oxide